UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047659
Receipt number R000054255
Scientific Title Historical data collection with J-CAT and J-CAT PRIME for pure cerebellar type spinocerebellar degeneration
Date of disclosure of the study information 2022/05/09
Last modified on 2023/05/06 11:06:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Historical data collection with J-CAT and J-CAT PRIME for pure cerebellar type spinocerebellar degeneration

Acronym

J-CAT PRIME

Scientific Title

Historical data collection with J-CAT and J-CAT PRIME for pure cerebellar type spinocerebellar degeneration

Scientific Title:Acronym

J-CAT PRIME

Region

Japan


Condition

Condition

spinocerebellar degeneration

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To elucidate etiology and pathomechanism of spinocerebellar degeneration, and research and development for new therapies.

Basic objectives2

Others

Basic objectives -Others

To collect clinical information of spinocerebellar degeneration patients in a sustained manner for a long time period, and to utilize the registry data for pharmaceuticals development.

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

SARA
mRS
Flow-FIM

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. written consent form of patient for entry into the registry is available
2. patient over 18 years old
3. patients with spinocerebellar ataxia type 6 (SCA6) or spinocerebellar ataxia type 31 (SCA31) and registered in J-CAT

Key exclusion criteria

1. Patients with dementia
2. Determined by investigators to be ineligible to participate in this study

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hidehiro
Middle name
Last name Mizusawa

Organization

National Center of Neurology and Psychiatry

Division name

The board of directors

Zip code

187-8551

Address

4-1-1, Ogawa-higashi, Kodaira, Tokyo 187-8551, Japan

TEL

0423412711

Email

mizusawa@ncnp.go.jp


Public contact

Name of contact person

1st name Takami
Middle name
Last name Ishizuka

Organization

National Center of Neurology and Psychiatry

Division name

Section of Clinical Research Support, Clinical Research and Education Promotion Division

Zip code

187-8551

Address

4-1-1, Ogawa-higashi, Kodaira, Tokyo 187-8551, Japan

TEL

0423412711

Homepage URL

http://jcat.umin.ne.jp/

Email

ishizukatakami@ncnp.go.jp


Sponsor or person

Institute

National Center of Neurology and Psychiatry

Institute

Department

Personal name



Funding Source

Organization

KISSEI PHARMACEUTICAL CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Center of Neurology and Psychiatry

Address

4-1-1, Ogawa-higashi, Kodaira, Tokyo 187-8551, Japan

Tel

042-341-2711

Email

ml_rinrijimu@ncnp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

新潟大学(新潟県)/Niigata University、千葉大学(千葉県)/Chiba University、岐阜大学(岐阜県)/Gifu University、鹿児島大学(鹿児島県)/Kagoshima University、笛吹中央病院(山梨県)/Fuefuki Central Hospital、横浜市立大学(神奈川県)/Yokohama City University、近畿大学(大阪府)/Kindai University、鳥取大学(鳥取県)/Tottori University、北海道大学(北海道)/Hokkaido University、信州大学(長野県)/Shinshu University、群馬大学(群馬県)/Gunma University、名古屋大学(愛知県)/Nagoya University、東京大学(東京都)/The University of Tokyo、東京慈恵会医科大学(東京都)/The Jikei University、東京医科歯科大学(東京都)/Tokyo Medical and Dental University、大阪大学(大阪府)/Osaka University、焼津市立総合病院(静岡県)/Yaizu City Hospital


Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 01 Month 18 Day

Date of IRB

2022 Year 02 Month 04 Day

Anticipated trial start date

2022 Year 05 Month 31 Day

Last follow-up date

2027 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2022 Year 05 Month 06 Day

Last modified on

2023 Year 05 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054255


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name